Who owns Nuvation Bio Inc. (NUVB)? Elite investor 13F holders
6 tracked elite investors reported holding Nuvation Bio Inc as of 2026-06-30, including D.E. Shaw, Renaissance Technologies LLC, Abrams Capital Management, Tudor Investment, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
6 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| D.E. Shaw | Nuvation Bio Inc - US | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 28759898.00 USD | 27500000.000000 | Principal | buy | Original filing |
| Duquesne Family Office | NUVATION BIO INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Renaissance Technologies LLC | NUVATION BIO INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 7645252.00 USD | 1345995.000000 | Shares | add | Original filing |
| Abrams Capital Management | NUVATION BIO INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 7216463.00 USD | 1270504.000000 | Shares | hold | Original filing |
| D.E. Shaw | NUVATION BIO INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 6475200.00 USD | 1140000.000000 | Shares | add | Original filing |
| Tudor Investment | Nuvation Bio Inc - US | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3663275.00 USD | 3500000.000000 | Shares | buy | Original filing |
| Gotham Asset Management | NUVATION BIO INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1034623.00 USD | 182152.000000 | Shares | buy | Original filing |
| Tudor Investment | NUVATION BIO INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Greenlight Capital | NUVATION BIO INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 198772.00 USD | 34995.000000 | Shares | hold | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.